12 results on '"González-García K"'
Search Results
2. APORTES CIENTÍFICOS AL CONOCIMIENTO FITOQUÍMICO Y ANTIMICROBIANO DE ZANTHOXYLUM ELEPHANTIASIS MACF.
- Author
-
González-García, K., Rivas De La Vega, Y., González-Mesa, L., Nodal, L., Prieto-González, S., and González-Lavaut, J. A.
- Abstract
Zanthoxylum elephantiasis es una de las 25 especies del género que crecen en Cuba y a la cual se le atribuyen propiedades etnomédicas tales como antimicrobiana, analgésica y antiartrítico. En el tamizaje fitoquímico preliminar, realizado a la corteza de esta especie colectada en dos años (2001 y 2002) en la provincia Pinar del Río, se detectó, en mayor proporción, la presencia de alcaloides, fenoles-taninos, triterpenos y esteroides. Se evalúa la actividad antimicrobiana de los extractos alcohólicos e hidroalcohólicos obtenidos, frente a diferentes microorganismos que incluye bacterias, hongos y levaduras. Los extractos etanólicos e hidroalcohólicos de Z. elephantiasis Macf. muestran actividad antifúngica y el tiempo de vigencia de la acción se presenta en las muestras colectadas hasta tres años; sin embargo, con cuatro años de tomadas las muestras no presentan actividad, lo cual permite determinar la fecha de vigencia en el almacenamiento de las especies colectadas y de esta forma hacia la búsqueda de algún agente con esta actividad. El trabajo resulta novedoso, pues se estudia por primera vez esta especie que crece en Cuba y constituye un paso de avance en la búsqueda de nuevos fármacos. [ABSTRACT FROM AUTHOR]
- Published
- 2005
3. Discovery of candidate biomarkers from plasma-derived extracellular vesicles of patients with cirrhosis and hepatocellular carcinoma: an exploratory proteomic study.
- Author
-
Zertuche-Martínez C, Velázquez-Enríquez JM, González-García K, Santos-Álvarez JC, Romero-Tlalolini MLÁ, Pina-Canseco S, Pérez-Campos Mayoral L, Muriel P, Villa-Treviño S, Baltiérrez-Hoyos R, Arellanes-Robledo J, and Vásquez-Garzón VR
- Subjects
- Humans, Male, Female, Middle Aged, Tandem Mass Spectrometry, Proteome metabolism, Chromatography, Liquid, Biomarkers blood, Carcinoma, Hepatocellular blood, Carcinoma, Hepatocellular metabolism, Liver Neoplasms blood, Liver Neoplasms metabolism, Extracellular Vesicles metabolism, Liver Cirrhosis blood, Liver Cirrhosis metabolism, Proteomics methods, Biomarkers, Tumor blood
- Abstract
Extracellular vesicles (EVs) represent an attractive source of biomarkers due to their biomolecular cargo. The aim of this study was to identify candidate protein biomarkers from plasma-derived EVs of patients with liver cirrhosis (LC) and hepatocellular carcinoma (HCC). Plasma-derived EVs from healthy participants (HP), LC, and HCC patients (eight samples each) were subjected to label-free quantitative proteomic analysis using LC-MS/MS. A total of 248 proteins were identified, and differentially expressed proteins (DEPs) were obtained after pairwise comparison. We found that DEPs mainly involve complement cascade activation, coagulation pathways, cholesterol metabolism, and extracellular matrix components. By choosing a panel of up- and down-regulated proteins involved in cirrhotic and carcinogenesis processes, TGFBI, LGALS3BP, C7, SERPIND1, and APOC3 were found to be relevant for LC patients, while LRG1, TUBA1C, TUBB2B, ACTG1, C9, HP, FGA, FGG, FN1, PLG, APOB and ITIH2 were associated with HCC patients, which could discriminate both diseases. In addition, we identified the top shared proteins in both diseases, which included LCAT, SERPINF2, A2M, CRP, and VWF. Thus, our exploratory proteomic study revealed that these proteins might play an important role in the disease progression and represent a panel of candidate biomarkers for the prognosis and diagnosis of LC and HCC.
- Published
- 2024
- Full Text
- View/download PDF
4. Identification of ABCC3 and its isoforms as potential biomarker in hepatocellular carcinoma.
- Author
-
Zertuche-Martínez C, Velázquez-Enríquez JM, González-García K, Baltiérrez-Hoyos R, Carrasco-Torres G, García-Román R, Romero-Díaz RI, Pérez-Hernández JL, Muriel P, Villa-Treviño S, Arellanes-Robledo J, and Vásquez-Garzón VR
- Subjects
- Humans, Case-Control Studies, Liver Cirrhosis diagnosis, Biomarkers, Tumor, Protein Isoforms, Carcinoma, Hepatocellular diagnosis, Carcinoma, Hepatocellular metabolism, Liver Neoplasms metabolism
- Abstract
Liver diseases preceding the occurrence of hepatocellular carcinoma (HCC) play a crucial role in the progression and establishment of HCC, a malignancy ranked as the third deadliest cancer worldwide. Late diagnosis, alongside ineffective treatment, leads patients to a poor survival rate. This scenario argues for seeking novel alternatives for detecting liver alterations preceding the early occurrence of HCC. Experimental studies have reported that ABCC3 protein increases within HCC tumors but not in adjacent tissue. Therefore, we analyzed ABCC3 expression in public databases and investigated the presence of ABCC3 and its isoforms in plasma, urine and its release in extracellular vesicles (EVs) cargo from patients bearing cirrhosis and HCC. The UALCAN and GEPIA databases were used to analyze the expression of ABCC3 in HCC. The results were validated in a case-control study including 41 individuals bearing cirrhosis and HCC, and the levels of ABCC3 in plasma and urine samples, as well as EVs, were analyzed by ELISA and western blot. Our data showed that ABCC3 expression was higher in HCC tissues than in normal tissues and correlated with HCC grade and stage. ABCC3 protein levels were highly increased in both plasma and urine and correlated with liver disease progression and severity. The isoforms MRP3A and MRP3B of ABCC3 were significantly increased in both EVs and plasma/urine of patients bearing HCC. ABCC3 expression gradually increases in HCC tissues, and its protein levels are increased in both plasma and urine of patients with cirrhosis and HCC. MRP3A and MRP3B isoforms have the potential to be prognostic biomarkers of HCC.
- Published
- 2024
- Full Text
- View/download PDF
5. Coadministration of 3'5-dimaleamylbenzoic acid and quercetin decrease pulmonary fibrosis in a systemic sclerosis model.
- Author
-
Reyes-Jiménez E, Ramírez-Hernández AA, Santos-Álvarez JC, Velázquez-Enríquez JM, González-García K, Carrasco-Torres G, Villa-Treviño S, Baltiérrez-Hoyos R, and Vásquez-Garzón VR
- Subjects
- Mice, Animals, Quercetin therapeutic use, Quercetin pharmacology, Fibrosis, Collagen metabolism, Bleomycin adverse effects, Disease Models, Animal, Lung pathology, Pulmonary Fibrosis chemically induced, Pulmonary Fibrosis drug therapy, Pulmonary Fibrosis metabolism, Scleroderma, Systemic metabolism
- Abstract
Systemic sclerosis (SSc) is an autoimmune disease characterized by microvascular compromise and fibrosis. Pulmonary fibrosis, a prominent pulmonary complication in SSc, results in impaired lung function due to excessive accumulation of extracellular matrix components. This study aimed to investigate the effects of coadministration of 3'5-dimaleamylbenzoic acid (AD) and quercetin (Q) on key events in the development and maintenance of pulmonary fibrosis in a bleomycin (BLM)-induced SSc mouse model. The model was induced in CD1 mice through BLM administration using osmotic mini pumps. Subsequently, mice were treated with AD (6 mg/kg) plus Q (10 mg/kg) and sacrificed at 21 and 28 days post BLM administration. Histopathological analysis was performed by hematoxylin and eosin staining and Masson's trichrome staining. Immunohistochemistry was used to determine the expression of proliferation, proinflammatory, profibrotic and oxidative stress markers. The coadministration of AD and Q during the fibrotic phase of the BLM-induced SSc model led to attenuated histological alterations and pulmonary fibrosis, reflected in the recovery of alveolar spaces (30 %, p < 0.01) and decreased collagen deposits (50 %, p < 0.001). This effect was achieved by decreasing the expression of the proliferative markers cyclin D1 (87 %, p < 0.0001) and PCNA (43 %, p < 0.0001), inflammatory markers COX-2 (71 %, p < 0.0001) and iNOS (84 %, p < 0.0001), profibrotic markers α-SMA (80 %, p < 0.0001) and TGF-β (81 %, p < 0.0001) and the lipid peroxidation marker 4-HNE (43 %, p < 0.01). The antifibrotic effect of this combined therapy is associated with the regulation of proliferation, inflammation and oxidative stress, mechanisms involved in the development and progression of the fibrotic process. Our novel therapeutic strategy is the first approach to propose the use of the combination of prooxidant and antioxidant compounds as a potential strategy for SSc-associated pulmonary fibrosis., Competing Interests: Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper., (Copyright © 2023 Elsevier B.V. All rights reserved.)
- Published
- 2023
- Full Text
- View/download PDF
6. Exoprotease exploitation and social cheating in a Pseudomonas aeruginosa environmental lysogenic strain with a noncanonical quorum sensing system.
- Author
-
Huelgas-Méndez D, Cazares D, Alcaraz LD, Ceapã CD, Cocotl-Yañez M, Shotaro T, Maeda T, Fernández-Presas AM, Tostado-Islas O, González-Vadillo AL, Limones-Martínez A, Hernandez-Cuevas CE, González-García K, Jiménez-García LF, Martínez RL, Santos-López CS, Husain FM, Khan A, Arshad M, Kokila K, Wood TK, and García-Contreras R
- Subjects
- Humans, Caseins genetics, Caseins metabolism, Bacterial Proteins genetics, Bacterial Proteins metabolism, Lysogeny, Prophages genetics, Quorum Sensing genetics, Pseudomonas aeruginosa genetics
- Abstract
Social cheating is the exploitation of public goods that are costly metabolites, like exoproteases. Exoprotease exploitation in Pseudomonas aeruginosa has been studied in reference strains. Experimental evolution with reference strains during continuous growth in casein has demonstrated that nonexoprotease producers that are lasR mutants are selected while they behave as social cheaters. However, noncanonical quorum-sensing systems exist in P. aeruginosa strains, which are diverse. In this work, the exploitation of exoproteases in the environmental strain ID4365 was evaluated; ID4365 has a nonsense mutation that precludes expression of LasR. ID4365 produces exoproteases under the control of RhlR, and harbors an inducible prophage. As expected, rhlR mutants of ID4365 behave as social cheaters, and exoprotease-deficient individuals accumulate upon continuous growth in casein. Moreover, in all continuous cultures, population collapses occur. However, this also sometimes happens before cheaters dominate. Interestingly, during growth in casein, ID4565's native prophage is induced, suggesting that the metabolic costs imposed by social cheating may increase its induction, promoting population collapses. Accordingly, lysogenization of the PAO1 lasR mutant with this prophage accelerated its collapse. These findings highlight the influence of temperate phages in social cheating., (© The Author(s) 2023. Published by Oxford University Press on behalf of FEMS.)
- Published
- 2023
- Full Text
- View/download PDF
7. Evaluation of renal damage in a bleomycin-induced murine model of systemic sclerosis.
- Author
-
Pérez-Figueroa DC, Reyes-Jiménez E, Velázquez-Enríquez JM, Reyes-Avendaño I, González-García K, Villa-Treviño S, Torres-Aguilar H, Baltiérrez-Hoyos R, and Vásquez-Garzón VR
- Abstract
Objectives: Systemic sclerosis (SSc) is an autoimmune disease of unknown etiology with a high mortality rate. Renal crisis has been reported as one of the predictors of early mortality in these patients. The present study was performed to evaluate bleomycin-induced SSc using an osmotic minipump as a possible model for the analysis of renal damage in SSc., Materials and Methods: Male CD1 mice were implanted with osmotic minipumps loaded with saline or bleomycin and sacrificed at 6 and 14 days. Histopathological analysis was performed through hematoxylin and eosin (H&E) and Masson's trichrome staining. The expression of endothelin 1 (ET-1), inducible nitric oxide synthase (iNOS), transforming growth factor β (TGF-β), and 8-hydroxy-2-deoxyguanosine (8-OHdG) was also evaluated by immunohistochemistry., Results: The administration of bleomycin induced a decrease in the length of Bowman's space (3.6 μm, P <0.001); an increase in collagen deposition (14.6%, P <0.0001); and an increase in the expression of ET-1 (7.5%, P <0.0001), iNOS (10.8%, P <0.0001), 8-OHdG (161 nuclei, P <0.0001), and TGF-β (2.4% µm, P <0.0001) on Day 6. On Day 14, a decrease in the length of Bowman's space (2.6 μm, P <0.0001); increased collagen deposition (13.4%, P <0.0001); and increased expression of ET-1 (2.7%, P <0.001), iNOS (10.1%, P <0.0001), 8-OHdG (133 nuclei, P <0.001), and TGF-β (0.6%, P <0.0001) were also observed., Conclusion: Systemic administration of bleomycin via an osmotic minipump produces histopathological changes in the kidneys, similar to kidney damage in SSc. Therefore, this model would allow the study of molecular alterations associated with SSc-related renal damage., Competing Interests: The authors declare that they have no conflicts of interest.
- Published
- 2023
- Full Text
- View/download PDF
8. 3'5-Dimaleamylbenzoic Acid Attenuates Bleomycin-Induced Pulmonary Fibrosis in Mice.
- Author
-
González-García K, López-Martínez A, Velázquez-Enríquez JM, Zertuche-Martínez C, Carrasco-Torres G, Sánchez-Navarro LM, Villa-Treviño S, Baltiérrez-Hoyos R, and Vásquez-Garzón VR
- Subjects
- Animals, Anti-Inflammatory Agents pharmacology, Collagen metabolism, Lung pathology, Mice, Mice, Inbred C57BL, Transforming Growth Factor beta1 metabolism, Bleomycin adverse effects, Idiopathic Pulmonary Fibrosis chemically induced, Idiopathic Pulmonary Fibrosis drug therapy, Idiopathic Pulmonary Fibrosis metabolism
- Abstract
Idiopathic pulmonary fibrosis (IPF) is a chronic lung disease characterized by parenchymal scarring, leading progressively to alveolar architecture distortion, respiratory failure, and eventually death. Currently, there is no effective treatment for IPF. Previously, 3'5-dimaleamylbenzoic acid (3'5-DMBA), a maleimide, demonstrated pro-apoptotic, anti-inflammatory, and anti-cancer properties; however, its potential therapeutic effects on IPF have not been addressed. Bleomycin (BLM) 100 U/kg was administered to CD1 mice through an osmotic minipump. After fourteen days of BLM administration, 3'5-DMBA (6 mg/kg or 10 mg/kg) and its vehicle carboxymethylcellulose (CMC) were administered intragastrically every two days until day 26. On day 28, all mice were euthanized. The 3'5-DMBA effect was assessed by histological and immunohistochemical staining, as well as by RT-qPCR. The redox status on lung tissue was evaluated by determining the glutathione content and the GSH/GSSG ratio. 3'5-DMBA treatment re-established typical lung histological features and decreased the expression of BLM-induced fibrotic markers: collagen, α-SMA, and TGF-β1. Furthermore, 3'5-DMBA significantly reduced the expression of genes involved in fibrogenesis. In addition, it decreased reduced glutathione and increased oxidized glutathione content without promoting oxidative damage to lipids, as evidenced by the decrease in the lipid peroxidation marker 4-HNE. Therefore, 3'5-DMBA may be a promising candidate for IPF treatment.
- Published
- 2022
- Full Text
- View/download PDF
9. Proteomic Analysis Reveals Differential Expression Profiles in Idiopathic Pulmonary Fibrosis Cell Lines.
- Author
-
Velázquez-Enríquez JM, Ramírez-Hernández AA, Navarro LMS, Reyes-Avendaño I, González-García K, Jiménez-Martínez C, Castro-Sánchez L, Sánchez-Chino XM, Vásquez-Garzón VR, and Baltiérrez-Hoyos R
- Subjects
- Cell Line, Chromatography, Liquid, Extracellular Matrix Proteins metabolism, Fibroblasts metabolism, Humans, Proteome metabolism, Tandem Mass Spectrometry methods, Idiopathic Pulmonary Fibrosis genetics, Idiopathic Pulmonary Fibrosis metabolism, Proteomics methods
- Abstract
Idiopathic pulmonary fibrosis (IPF) is a chronic, progressive, irreversible lung disorder of unknown cause. This disease is characterized by profibrotic activation of resident pulmonary fibroblasts resulting in aberrant deposition of extracellular matrix (ECM) proteins. However, although much is known about the pathophysiology of IPF, the cellular and molecular processes that occur and allow aberrant fibroblast activation remain an unmet need. To explore the differentially expressed proteins (DEPs) associated with aberrant activation of these fibroblasts, we used the IPF lung fibroblast cell lines LL97A (IPF-1) and LL29 (IPF-2), compared to the normal lung fibroblast cell line CCD19Lu (NL-1). Protein samples were quantified and identified using a label-free quantitative proteomic analysis approach by liquid chromatography-tandem mass spectrometry (LC-MS/MS). DEPs were identified after pairwise comparison, including all experimental groups. Gene Ontology (GO) enrichment analysis, Kyoto Encyclopedia of Genes and Genomes (KEGG), and Protein-Protein Interaction (PPI) network construction were used to interpret the proteomic data. Eighty proteins expressed exclusively in the IPF-1 and IPF-2 clusters were identified. In addition, 19 proteins were identified up-regulated in IPF-1 and 10 in IPF-2; 10 proteins were down-regulated in IPF-1 and 2 in IPF-2 when compared to the NL-1 proteome. Using the search tool for retrieval of interacting genes/proteins (STRING) software, a PPI network was constructed between the DEPs and the 80 proteins expressed exclusively in the IPF-2 and IPF-1 clusters, containing 115 nodes and 136 edges. The 10 hub proteins present in the IPP network were identified using the CytoHubba plugin of the Cytoscape software. GO and KEGG pathway analyses showed that the hub proteins were mainly related to cell adhesion, integrin binding, and hematopoietic cell lineage. Our results provide relevant information on DEPs present in IPF lung fibroblast cell lines when compared to the normal lung fibroblast cell line that could play a key role during IPF pathogenesis.
- Published
- 2022
- Full Text
- View/download PDF
10. miRNAs Contained in Extracellular Vesicles Cargo Contribute to the Progression of Idiopathic Pulmonary Fibrosis: An In Vitro Aproach.
- Author
-
Santos-Álvarez JC, Velázquez-Enríquez JM, García-Carrillo R, Rodríguez-Beas C, Ramírez-Hernández AA, Reyes-Jiménez E, González-García K, López-Martínez A, Pérez-Campos Mayoral L, Aguilar-Ruiz SR, Romero-Tlalolini MLÁ, Torres-Aguilar H, Castro-Sánchez L, Arellanes-Robledo J, Vásquez-Garzón VR, and Baltiérrez-Hoyos R
- Subjects
- Cell Communication, Fibroblasts metabolism, Humans, Extracellular Vesicles metabolism, Idiopathic Pulmonary Fibrosis pathology, MicroRNAs genetics, MicroRNAs metabolism
- Abstract
Idiopathic pulmonary fibrosis (IPF) is a chronic, progressive lung disease. Lesions in the lung epithelium cause alterations in the microenvironment that promote fibroblast accumulation. Extracellular vesicles (EVs) transport proteins, lipids, and nucleic acids, such as microRNAs (miRNAs). The aim of this study was to characterize the differentially expressed miRNAs in the cargo of EVs obtained from the LL97 and LL29 fibroblast cell lines isolated from IPF lungs versus those derived from the CCD19 fibroblast cell line isolated from a healthy donors. We characterized EVs by ultracentrifugation, Western blotting, and dynamic light scattering. We identified miRNAs by small RNA-seq, a total of 1144 miRNAs, of which 1027 were known miRNAs; interestingly, 117 miRNAs were novel. Differential expression analysis showed that 77 miRNAs were upregulated and 68 were downregulated. In addition, pathway enrichment analyses from the Gene Ontology and Kyoto Encyclopedia of Genomes identified several miRNA target genes in the categories, cell proliferation, regulation of apoptosis, pathways in cancer, and proteoglycans in cancer. Our data reveal that miRNAs contained in EVs cargo could be helpful as biomarkers for fibrogenesis, diagnosis, and therapeutic intervention of IPF.
- Published
- 2022
- Full Text
- View/download PDF
11. The Role of Extracellular Vesicles in Idiopathic Pulmonary Fibrosis Progression: An Approach on Their Therapeutics Potential.
- Author
-
Ramírez-Hernández AA, Velázquez-Enríquez JM, Santos-Álvarez JC, López-Martínez A, Reyes-Jiménez E, Carrasco-Torres G, González-García K, Vásquez-Garzón VR, and Baltierrez-Hoyos R
- Subjects
- Cell Communication, Fibroblasts metabolism, Humans, Extracellular Vesicles metabolism, Idiopathic Pulmonary Fibrosis metabolism, Idiopathic Pulmonary Fibrosis therapy, Lung Diseases, Interstitial complications
- Abstract
Idiopathic pulmonary fibrosis (IPF) is a fibrosing interstitial lung disease of unknown etiology. Different types of cells are involved in fibrogenesis, which is persistently physical and molecular stimulation, either directly or by interacting with bioactive molecules and extracellular vesicles (EVs). Current evidence suggests that EVs play an essential role in IPF development. EVs are released by a variety of cells, including fibroblasts, epithelial cells, and alveolar macrophages. In addition, EVs can transport bioactive molecules, such as lipids, proteins, and nucleic acids, which play a pivotal role in cellular communication. Several proposed mechanisms show that an acceptor cell can capture, absorb, or interact with EVs through direct fusion with the plasma membrane, ligand-receptor interaction, and endocytotic process, modifying the target cell. During fibrogenesis, the release of EVs is deregulated, increases the EVs amount, and the cargo content is modified. This alteration is closely associated with the maintenance of the fibrotic microenvironment. This review summarizes the current data on the participation of EVs secreted by the cells playing a critical role in IPF pathogenesis.
- Published
- 2022
- Full Text
- View/download PDF
12. Quercetin Regulates Key Components of the Cellular Microenvironment during Early Hepatocarcinogenesis.
- Author
-
Reyes-Avendaño I, Reyes-Jiménez E, González-García K, Pérez-Figueroa DC, Baltiérrez-Hoyos R, Tapia-Pastrana G, Sánchez-Chino XM, Villa-Treviño S, Arellanes-Robledo J, and Vásquez-Garzón VR
- Abstract
Hepatocellular carcinoma (HCC) is a health problem worldwide due to its high mortality rate, and the tumor microenvironment (TME) plays a key role in the HCC progression. The current ineffective therapies to fight the disease still warrant the development of preventive strategies. Quercetin has been shown to have different antitumor activities; however, its effect on TME components in preneoplastic lesions has not been fully investigated yet. Here, we aimed to evaluate the effect of quercetin (10 mg/kg) on TME components during the early stages of HCC progression induced in the rat. Histopathological and immunohistochemical analyses showed that quercetin decreases the size of preneoplastic lesions, glycogen and collagen accumulation, the expression of cancer stem cells and myofibroblasts markers, and that of the transporter ATP binding cassette subfamily C member 3 (ABCC3), a marker of HCC progression and multi-drug resistance. Our results strongly suggest that quercetin has the capability to reduce key components of TME, as well as the expression of ABCC3. Thus, quercetin can be an alternative treatment for inhibiting the growth of early HCC tumors.
- Published
- 2022
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.